Are you 18 years or older? Are you being treated with lifestyle changes or treated with one or more oral diabetes medications?

At a glance:

The University of Alabama at Birmingham, Department of Nutrition Sciences, in collaboration with Novo Nordisk, is conducting a 78 week research study to look into how well semaglutide once weekly medicine works in participants with obesity and type 2 diabetes.

Qualified participants will receive study drug free of charge and may be compensated for time and travel.

For more information, and to see if you might be eligible to join, please contact Dana Sides at (205) 996-4015 or email mailto:This email address is being protected from spambots. You need JavaScript enabled to view it..

PI: Dr. Tim Garvey

Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.